Beacon Capital Management LLC (Tennessee)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Sell
1,797
-61
-3% -$62.3K 0.32% 37
2026
Q1
$1.71M Buy
1,858
+15
+0.8% +$15.2K 0.3% 36
2025
Q4
$1.98M Buy
1,843
+126
+7% +$120K 0.31% 29
2025
Q3
$1.31M Sell
1,717
-71
-4% -$52.8K 0.19% 41
2025
Q2
$1.39M Sell
1,788
-113
-6% -$87.8K 0.19% 34
2025
Q1
$1.57M Sell
1,901
-6
-0.3% -$4.99K 0.21% 30
2024
Q4
$1.47M Buy
1,907
+3
+0.2% +$2.48K 0.19% 32
2024
Q3
$1.69M Buy
1,904
+67
+4% +$60.2K 0.24% 25
2024
Q2
$1.66M Sell
1,837
-1
-0.1% -$800 0.31% 23
2024
Q1
$1.43M Buy
1,838
+717
+64% +$510K 0.29% 23
2023
Q4
$602K Hold
1,121
0.17% 38
2023
Q3
$526K Hold
1,121
0.14% 40
2023
Q2
$526K Buy
1,121
+160
+17% +$67.1K 0.14% 40
2023
Q1
$330K Hold
961
0.1% 57
2022
Q4
$351K Buy
961
+254
+36% +$90.1K 0.12% 55
2022
Q3
$229K Sell
707
-136
-16% -$43.1K 0.08% 75
2022
Q2
$241K Hold
843
0.06% 81
2022
Q1
$241K Buy
+843
New +$217K 0.06% 81

Other funds holding LLY

Beacon Capital Management LLC (Tennessee)'s LLY Position: Q2 2026 in Review

Beacon Capital Management LLC (Tennessee) reduced its Eli Lilly (LLY) stake by 3.3% in Q2 2026, selling an estimated $62.3K and leaving 1,797 shares worth $2.16M. The position accounts for 0.32% of the portfolio, ranked #37.

Beacon Capital Management LLC (Tennessee) first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Beacon Capital Management LLC (Tennessee) held 1,797 shares of Eli Lilly worth $2.16M as of Q2 2026.
  • Beacon Capital Management LLC (Tennessee) sold 61 Eli Lilly shares in Q2 2026, an estimated $62.3K.
  • Eli Lilly made up 0.32% of Beacon Capital Management LLC (Tennessee)'s portfolio in Q2 2026, its #37 holding.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2026, filed 29 Jul 2026.